Cheng-Hung How1,2,†
Pei-Hsing Chen1,3,4,†
Yu-Ching Chen3
Yong-Chong Lin1
Ke-Cheng Chen4*Jin-Shing Chen4
Tai-Horng Young1*
- 1Institute of Biomedical Engineering, College of Medicine and College of Engineering, National Taiwan University, Taipei City, Taiwan
- 2Department of Surgery, Division of Thoracic Surgery, Far Eastern Memorial Hospital, Taipei City, Taiwan
- 3Division of Thoracic Surgery, Department of Surgery, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan
- 4Department of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei City, Taiwan
A Corrigendum on
Safety assessment of poly-ε-caprolactone in the treatment of primary spontaneous pneumothorax
By How C-H, Chen P-H, Chen Y-C, Lin Y-C, Chen K-C, Chen J-S and Young T-H (2024). Front. Surg. 11:1335144. doi: 10.3389/fsurg.2024.1335144
Incorrect Funding
In the published article, there was an error in the Funding statement. [The author acknowledges the support from the National Science and Technology Council project, Grant No. 112-2314-B-002-226-MY3. This research was jointly supported by the Far Eastern Memorial Hospital and the National Taiwan University Hospital Joint Research Program.]. The correct Funding statement appears below.
Funding
The author(s) declare that financial support was received for the research, authorship, and/or publication of this article.
The author acknowledges the support from the National Science and Technology Council project, Grant No. 112-2314-B-002-226-MY3 and 110-2314-B-002-037-MY3. This research was jointly supported by the Far Eastern Memorial Hospital and the National Taiwan University Hospital Joint Research Program.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: pleurodesis, pneumothorax, poly-ε-caprolactone, thoracoscopy, Phase I trial
Citation: How C-H, Chen P-H, Chen Y-C, Lin Y-C, Chen K-C, Chen J-S and Young T-H (2024) Corrigendum: Safety assessment of poly-ε-caprolactone in the treatment of primary spontaneous pneumothorax. Front. Surg. 11:1386747. doi: 10.3389/fsurg.2024.1386747
Received: 16 February 2024; Accepted: 19 February 2024;
Published: 29 February 2024.
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
© 2024 How, Chen, Chen, Lin, Chen, Chen and Young. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ke-Cheng Chen cskchen@gmail.com Tai-Horng Young thyoung@ntu.edu.tw
†These authors have contributed equally to this work and share first authorship